




Searching News Database: McNeil
HSMN NewsFeed - 10 Aug 2015
Aratana Therapeutics Elects Wendy Yarno as Chairman of the Board of Directors
Aratana Therapeutics Elects Wendy Yarno as Chairman of the Board of Directors
HSMN NewsFeed - 8 Jul 2015
Synergy Pharmaceuticals Appoints Troy Hamilton as Chief Commercial Officer
Synergy Pharmaceuticals Appoints Troy Hamilton as Chief Commercial Officer
HSMN NewsFeed - 5 May 2014
SAGE Therapeutics Appoints Thomas D. Anderson as Chief Commercial Strategy Officer
SAGE Therapeutics Appoints Thomas D. Anderson as Chief Commercial Strategy Officer
HSMN NewsFeed - 17 Jul 2013
Intarcia Therapeutics Appoints Dr. Eddie Li Vice President and Global Head of Regulatory Affairs
Intarcia Therapeutics Appoints Dr. Eddie Li Vice President and Global Head of Regulatory Affairs
HSMN NewsFeed - 24 Jun 2013
Exalenz Bioscience Names Ted Foltyn New VP of Worldwide Marketing and Business Development
Exalenz Bioscience Names Ted Foltyn New VP of Worldwide Marketing and Business Development
HSMN NewsFeed - 5 Dec 2012
Savient Announces the Election of Robert G. Savage to its Board of Directors
Savient Announces the Election of Robert G. Savage to its Board of Directors
HSMN NewsFeed - 10 May 2012
Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer
Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer
HSMN NewsFeed - 24 Apr 2012
Genta Appoints Dr. Brian Leyland-Jones and Richard J. Moran to Its Board of Directors
Genta Appoints Dr. Brian Leyland-Jones and Richard J. Moran to Its Board of Directors
HSMN NewsFeed - 16 Mar 2012
Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer
Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer
HSMN NewsFeed - 27 Sep 2011
Cardinal Health Introduces New Latex, Powder-Free, Hydrogel Surgical Gloves
Cardinal Health Introduces New Latex, Powder-Free, Hydrogel Surgical Gloves
HSMN NewsFeed - 19 Jan 2011
Momenta Pharmaceuticals Announces Appointment of Thomas P. Koestler to Board of Directors
Momenta Pharmaceuticals Announces Appointment of Thomas P. Koestler to Board of Directors
HSMN NewsFeed - 14 Jan 2011
Orexo and Invida Jointly Announce Agreement for Abstral(TM) in Asia Pacific
Orexo and Invida Jointly Announce Agreement for Abstral(TM) in Asia Pacific
HSMN NewsFeed - 10 Jan 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
HSMN NewsFeed - 1 Sep 2010
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
HSMN NewsFeed - 24 May 2010
IDEV Technologies Names Veteran Healthcare Executive Dennis Donohoe, M.D. Chief Medical Officer
IDEV Technologies Names Veteran Healthcare Executive Dennis Donohoe, M.D. Chief Medical Officer
HSMN NewsFeed - 27 Oct 2009
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
HSMN NewsFeed - 15 Oct 2009
Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
HSMN NewsFeed - 14 Sep 2009
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
HSMN NewsFeed - 2 Apr 2009
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Topamax(R) Tablets
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Topamax(R) Tablets
HSMN NewsFeed - 27 Mar 2009
Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets
Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets
HSMN NewsFeed - 23 Mar 2009
Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
HSMN NewsFeed - 25 Feb 2009
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
HSMN NewsFeed - 31 Dec 2008
PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
HSMN NewsFeed - 16 Dec 2008
Watson Pharmaceuticals Receives FDA Approval for Generic Razadyne(R) ER Capsules
Watson Pharmaceuticals Receives FDA Approval for Generic Razadyne(R) ER Capsules
HSMN NewsFeed - 18 Aug 2008
Bausch & Lomb Names Presidents for Europe, Middle East, & Africa and Asia Pacific Regions
Bausch & Lomb Names Presidents for Europe, Middle East, & Africa and Asia Pacific Regions
HSMN NewsFeed - 24 Jul 2008
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
HSMN NewsFeed - 14 Jul 2008
Noven Names Joel Lippman, M.D. as Vice President - Clinical Development & Chief Medical Officer
Noven Names Joel Lippman, M.D. as Vice President - Clinical Development & Chief Medical Officer
HSMN NewsFeed - 15 May 2008
First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System
First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System
HSMN NewsFeed - 18 Apr 2008
Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
HSMN NewsFeed - 2 Jan 2008
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol
HSMN NewsFeed - 28 Dec 2007
Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets
Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets
HSMN NewsFeed - 12 Dec 2007
INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
HSMN NewsFeed - 16 Nov 2007
FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
HSMN NewsFeed - 17 Oct 2007
Phenomix Hires John Crawford as Chief Financial Officer and Appoints Arlene Morris to Board of Directors
Phenomix Hires John Crawford as Chief Financial Officer and Appoints Arlene Morris to Board of Directors
HSMN NewsFeed - 11 Oct 2007
McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products
McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products
HSMN NewsFeed - 3 Oct 2007
Postoperative Pain is an Under Appreciated, Under Treated Problem in the United States
Postoperative Pain is an Under Appreciated, Under Treated Problem in the United States
HSMN NewsFeed - 2 Oct 2007
Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
HSMN NewsFeed - 25 Sep 2007
ULURU Inc. Announces the Appointment of Renaat Van den Hooff to Join Executive Team
ULURU Inc. Announces the Appointment of Renaat Van den Hooff to Join Executive Team
HSMN NewsFeed - 14 Aug 2007
Physicians, Varicose Vein Patients Celebrate the VNUS ClosureFAST Catheter
Physicians, Varicose Vein Patients Celebrate the VNUS ClosureFAST Catheter
HSMN NewsFeed - 7 Aug 2007
NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
HSMN NewsFeed - 6 Aug 2007
Avalon Pharmaceuticals Appoints Bradley G. Lorimier Chairman of Board of Directors
Avalon Pharmaceuticals Appoints Bradley G. Lorimier Chairman of Board of Directors
HSMN NewsFeed - 19 Jul 2007
Ortho-McNeil, Inc. Settles Patent Infringement Litigation Against Par/Kali
Ortho-McNeil, Inc. Settles Patent Infringement Litigation Against Par/Kali
HSMN NewsFeed - 19 Jul 2007
Par Pharmaceutical Announces Agreement with Ortho-McNeil to Settle Ultracet(R) Patent Litigation
Par Pharmaceutical Announces Agreement with Ortho-McNeil to Settle Ultracet(R) Patent Litigation
HSMN NewsFeed - 7 Jun 2007
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
HSMN NewsFeed - 18 May 2007
New Drug Application Submitted For Novel Investigational Antibiotic Ceftobiprole
New Drug Application Submitted For Novel Investigational Antibiotic Ceftobiprole
HSMN NewsFeed - 9 May 2007
Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI-CYCLEN(R) LO In a Broad Range of Women
Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI-CYCLEN(R) LO In a Broad Range of Women
HSMN NewsFeed - 3 May 2007
Metabolex Names Charpentier to the Post of Vice President for Regulatory Affairs
Metabolex Names Charpentier to the Post of Vice President for Regulatory Affairs
HSMN NewsFeed - 3 Apr 2007
Angiotech appoints Chris Dennis as Senior Vice President, Sales and Marketing
Angiotech appoints Chris Dennis as Senior Vice President, Sales and Marketing
HSMN NewsFeed - 10 Nov 2006
Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets
Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets
HSMN NewsFeed - 27 Sep 2006
Avalon Pharmaceuticals Appoints David D. Muth to Executive Vice President, Chief Business Officer
Avalon Pharmaceuticals Appoints David D. Muth to Executive Vice President, Chief Business Officer
HSMN NewsFeed - 25 Sep 2006
Arena Pharmaceuticals Announces Update on Partnership With Merck in Development of Niacin Receptor Agonists
Arena Pharmaceuticals Announces Update on Partnership With Merck in Development of Niacin Receptor Agonists
HSMN NewsFeed - 12 Sep 2006
Icagen Reports Results of Data Monitoring Committee Meeting in Phase III Assert Trial of ICA-17043
Icagen Reports Results of Data Monitoring Committee Meeting in Phase III Assert Trial of ICA-17043
HSMN NewsFeed - 12 Sep 2006
Arena Pharmaceuticals Initiates Lorcaserin Phase 3 Obesity Clinical Trial
Arena Pharmaceuticals Initiates Lorcaserin Phase 3 Obesity Clinical Trial
HSMN NewsFeed - 11 Sep 2006
Ranbaxy Receives FDA Approval to Market Loperamide Hydrochloride and Simethicone Tablets
Ranbaxy Receives FDA Approval to Market Loperamide Hydrochloride and Simethicone Tablets
HSMN NewsFeed - 7 Sep 2006
U.S. Court of Appeals Rules in Favor of Mylan in Oxybutynin Patent Litigation
U.S. Court of Appeals Rules in Favor of Mylan in Oxybutynin Patent Litigation
HSMN NewsFeed - 12 Jul 2006
Schering-Plough Announces Executive Changes in Schering-Plough Research Institute
Schering-Plough Announces Executive Changes in Schering-Plough Research Institute
HSMN NewsFeed - 23 May 2006
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
HSMN NewsFeed - 6 Feb 2006
Mylan Announces FDA Approval for Cyclobenzaprine Hydrochloride Tablets USP, 5 mg
Mylan Announces FDA Approval for Cyclobenzaprine Hydrochloride Tablets USP, 5 mg
HSMN NewsFeed - 30 Jan 2006
European Commission Approves IONSYS(TM) (Fentanyl HCl Iontophoretic Transdermal System)
European Commission Approves IONSYS(TM) (Fentanyl HCl Iontophoretic Transdermal System)
HSMN NewsFeed - 23 Jan 2006
Recent Study Confirms REGRANEX Gel to be Effective Treatment of Diabetic Neuropathic Foot Ulcers
Recent Study Confirms REGRANEX Gel to be Effective Treatment of Diabetic Neuropathic Foot Ulcers
HSMN NewsFeed - 6 Jan 2006
Mpex Pharmaceuticals Appoints Matthew A. Wikler to the Position of Chief Medical Officer
Mpex Pharmaceuticals Appoints Matthew A. Wikler to the Position of Chief Medical Officer
HSMN NewsFeed - 3 Jan 2006
Arena Pharmaceuticals Appoints Robert E. Hoffman as Chief Financial Officer
Arena Pharmaceuticals Appoints Robert E. Hoffman as Chief Financial Officer
Additional items found! 133

Members Archive contains
133 additional stories matching:
McNeil
(Password required)
McNeil
(Password required)